Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
ERIS Lifesciences LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:540596NSE Symbol: ERISP/E(TTM):152.08
ISIN Demat:INE406M01024Div & Yield %:0EPS(TTM):8.54
Book Value(Rs):189.2952734Market Cap ( Cr.):17679.79Face Value(Rs):1
    Change Company 
(Rs In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
SOURCES OF FUNDS :      
Share Capital 13.6013.6013.5913.5813.5813.75
Reserves Total 2510.422208.291904.511561.891286.121142.26
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.450.000.000.00
Total Shareholders Funds2524.022221.891918.551575.471299.701156.01
Secured Loans 1457.84316.870.000.000.00175.92
Unsecured Loans 1071.610.000.000.000.000.00
Total Debt2529.45316.870.000.000.00175.92
Other Liabilities77.8368.5365.6234.8833.9923.73
Total Liabilities5131.302607.291984.171610.351333.691355.66
APPLICATION OF FUNDS :      
Gross Block 1811.191094.83778.40716.88695.65551.81
Less : Accumulated Depreciation 295.64197.02136.40132.5595.0167.96
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 1515.55897.81642.00584.33600.64483.85
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress0.610.342.981.564.372.73
Producing Properties0.000.000.000.000.000.00
Investments 1618.95996.52777.72531.37320.30580.47
Current Assets, Loans & Advances      
Inventories 91.6463.7084.7964.8565.4674.70
Sundry Debtors 239.97229.22137.56113.76140.8275.90
Cash and Bank1296.7447.6546.1132.6664.956.47
Loans and Advances 248.21181.50212.02161.98104.0986.60
Total Current Assets1876.55522.07480.47373.24375.32243.67
Less : Current Liabilities and Provisions      
Current Liabilities 175.58114.10123.38110.08114.3494.06
Provisions 42.6862.2742.8634.3835.1020.68
Total Current Liabilities218.27176.37166.24144.46149.44114.73
Net Current Assets1658.29345.70314.23228.78225.89128.94
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets485.08399.14350.70297.27240.62196.28
Deferred Tax Liability181.30125.36114.59100.5276.4658.50
Net Deferred Tax303.78273.78236.11196.75164.16137.78
Other Assets34.1293.1311.1467.5818.3321.88
Total Assets5131.312607.291984.191610.361333.691355.65
Contingent Liabilities332.46630.3924.3418.3215.8115.29